These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 21568748

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.
    Chabroux S, Canouï-Poitrine F, Reffet S, Mills-Joncour G, Morelon E, Colin C, Thivolet C.
    Diabetes Metab; 2010 Apr; 36(2):152-7. PubMed ID: 20137994
    [Abstract] [Full Text] [Related]

  • 3. Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study.
    Araszkiewicz A, Naskret D, Zozulinska-Ziolkiewicz D, Pilacinski S, Uruska A, Grzelka A, Wegner M, Wierusz-Wysocka B.
    Microvasc Res; 2015 Mar; 98():62-7. PubMed ID: 25582078
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ.
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [Abstract] [Full Text] [Related]

  • 6. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
    Noordzij MJ, Mulder DJ, Oomen PH, Brouwer T, Jager J, Castro Cabezas M, Lefrandt JD, Smit AJ.
    Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
    [Abstract] [Full Text] [Related]

  • 7. Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.
    de Vos LC, Noordzij MJ, Mulder DJ, Smit AJ, Lutgers HL, Dullaart RP, Kamphuisen PW, Zeebregts CJ, Lefrandt JD.
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):131-8. PubMed ID: 23139292
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Advanced glycation end products, measured as skin autofluorescence, at diagnosis in gestational diabetes mellitus compared with normal pregnancy.
    de Ranitz-Greven WL, Bos DC, Poucki WK, Visser GH, Beulens JW, Biesma DH, de Valk HW.
    Diabetes Technol Ther; 2012 Jan; 14(1):43-9. PubMed ID: 21875328
    [Abstract] [Full Text] [Related]

  • 13. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study.
    Duda-Sobczak A, Falkowski B, Araszkiewicz A, Zozulinska-Ziolkiewicz D.
    Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Skin autofluorescence in type 2 diabetes: beyond blood glucose.
    Monami M, Lamanna C, Gori F, Bartalucci F, Marchionni N, Mannucci E.
    Diabetes Res Clin Pract; 2008 Jan; 79(1):56-60. PubMed ID: 17707942
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V.
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [Abstract] [Full Text] [Related]

  • 19. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease.
    Hartog JW, de Vries AP, Lutgers HL, Meerwaldt R, Huisman RM, van Son WJ, de Jong PE, Smit AJ.
    Ann N Y Acad Sci; 2005 Jun; 1043():299-307. PubMed ID: 16037252
    [Abstract] [Full Text] [Related]

  • 20. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
    Adamska A, Araszkiewicz A, Pilacinski S, Gandecka A, Grzelka A, Kowalska K, Malinska A, Nowicki M, Zozulinska-Ziolkiewicz D.
    Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.